focus -WSS

focus

author：leisure time 2025-09-03 07:38:15 - browse：9

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： How the Dana

hotspot

WSS

Meadows told special counsel he could not recall Trump ever declassifying Mar

How the drug

WHO recommends dropping component of many flu vaccines

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Mindstrong's demise and the future of mental health care

Cigna to pay $172 million to settle Medicare Advantage fraud probe

focus

focus

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Medicaid, Medicare dual

Novavax promises a turnaround & Lilly roils the obesity market

Inequities make cancer less preventable for women: report

Medical records are filled with copy

WHO recommends dropping component of many flu vaccines

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Intellia plays down concerns on accidental germline transmission

focus

Medicare drug price negotiation program allowed for now

Vivek Ramaswamy made waves in the debate, much as in biotech

Intellia plays down concerns on accidental germline transmission

Medicaid, Medicare dual

How the Dana

Vivek Ramaswamy made waves in the debate, much as in biotech

knowledge

hotspot

focus

explore